Postoperative pain control. Other acute postprocedural pain
Conditions
Interventions
Intervention 1: Intervention group 1: Patients will receive 1 g Apotel, 16 mg dexamethasone, 16 mg ondansetron, and 10 mg morphine. Intervention 2: Intervention group 2: Patients will receive 16 mg de
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients scheduled for hysterectomy presenting to Sina Ashtiani Hospital. Having a written informed consent. American Society of Anesthesiologists (ASA) Physical Status Classification I, II
Exclusion criteria
Exclusion criteria: Presence of systemic diseases including renal, hepatic, cardiovascular disorders, hypertension, diabetes, or malignancy. Having a history of substance abuse or chronic analgesic consumption. Presence of known hypersensitivity to the study drugs and seasonal allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: In the recovery room and 2, 4, 8, 12 hours after surgery. Method of measurement: Visual analog scale.;Pain relief period. Timepoint: 24 hours after surgery. Method of measurement: History and physical examination.;Opioid consumption. Timepoint: 24 hours after surgery. Method of measurement: Patient file. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean arterial pressure. Timepoint: At the beginning of surgery and every 15 minutes until the end of surgery. Method of measurement: NIBP monitoring device.;Heart rate. Timepoint: At the beginning of surgery and every 15 minutes until the end of surgery. Method of measurement: Cardiac monitoring device.;Arterial blood oxygen saturation. Timepoint: At the beginning of surgery and every 15 minutes until the end of surgery. Method of measurement: Pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Alireza Kamali
Arak University of Medical Sciences
Outcome results
None listed